Invention Grant
- Patent Title: Method for treating pulmonary fibrosis using S100A3 protein
-
Application No.: US17080268Application Date: 2020-10-26
-
Publication No.: US11992515B2Publication Date: 2024-05-28
- Inventor: Eid Abdullah Al Mutairy , Mohammed Khalid , Futwan Al-Mohanna
- Applicant: KING FAISAL SPECIALIST HOSPITAL & RESEARCH CENTRE
- Applicant Address: SA Riyadh
- Assignee: KING FAISAL SPECIALIST HOSPITAL & RESEARCH CENTRE
- Current Assignee: KING FAISAL SPECIALIST HOSPITAL & RESEARCH CENTRE
- Current Assignee Address: SA Riyadh
- Agency: Oblon, McClelland, Maier & Neustadt, L.L.P.
- Main IPC: A61P11/00
- IPC: A61P11/00 ; A61K9/00 ; A61K38/00 ; A61K38/17 ; A61P9/04 ; A61P11/08 ; C07K14/47 ; C12N15/52 ; C12Q1/68 ; C12Q1/6813 ; C12Q1/6827
Abstract:
The invention is directed to a method for diagnosing and treating a pulmonary lung disease by detecting a mutant S100A3 protein associated with pulmonary lung disease and by treating a subject with a functional S100A3 protein.
Public/Granted literature
- US20210052700A1 METHOD FOR TREATING PULMONARY FIBROSIS USING S100A3 PROTEIN Public/Granted day:2021-02-25
Information query
